We are live on ! Find out more
FM

Family Management Portfolio holdings

AUM $975M
1-Year Est. Return 23.16%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+23.16%
3 Year Est. Return
+69.01%
5 Year Est. Return
+69.7%
10 Year Est. Return
+315.93%
AUM
$143M
AUM Growth
-$2.8M
Cap. Flow
-$11.6M
Cap. Flow %
-8.13%
Top 10 Hldgs %
44.58%
Holding
73
New
6
Increased
15
Reduced
36
Closed
14

Top Buys

Rank Stock Value
1
LEN icon
Lennar Class A
LEN
+$2.33M
2
BP icon
BP
BP
+$1.4M
3
RPT
Rithm Property Trust
RPT
+$1.12M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$669K
5
TYME
Tyme Technologies, Inc. Common Stock
TYME
+$491K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$4.07M
2
SLB icon
SLB Ltd
SLB
+$4.05M
3
AAPL icon
Apple
AAPL
+$2.96M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.11M
5
ABEO icon
Abeona Therapeutics
ABEO
+$614K

Sector Composition

Rank Sector Weight
1 Financials 21.7%
2 Technology 18.57%
3 Healthcare 13.07%
4 Communication Services 12.77%
5 Consumer Discretionary 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBDC icon
51
Barings BDC
BBDC
$979M
$267K 0.19%
+28,126
New +$308K
XPLR
52
DELISTED
Xplore Technologies Corp.
XPLR
$253K 0.18%
89,109
– –
INSG icon
53
Inseego
INSG
$72.3M
$249K 0.17%
15,450
+11,250
+268% +$175K
LXP icon
54
LXP Industrial Trust
LXP
$3.58B
$121K 0.08%
+2,502
New +$129K
GAB icon
55
Gabelli Equity Trust
GAB
$1.76B
$88K 0.06%
14,533
+1,715
+13% +$10.5K
LCTX icon
56
Lineage Cell Therapeutics
LCTX
$281M
$70K 0.05%
37,193
-171,233
-82% -$374K
SGYP
57
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$26K 0.02%
11,500
-69,000
-86% -$172K
AST
58
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$23K 0.02%
10,424
-47,000
-82% -$119K
GERN icon
59
Geron
GERN
$970M
$18K 0.01%
10,200
-15,000
-60% -$30.3K
ABEO icon
60
Abeona Therapeutics
ABEO
$339M
– –
-1,440
Closed -$614K
ACAD icon
61
Acadia Pharmaceuticals
ACAD
$5.02B
– –
-29,500
Closed -$1.11M
BMRN icon
62
BioMarin Pharmaceuticals
BMRN
$12.5B
– –
-3,000
Closed -$279K
EPD icon
63
Enterprise Products Partners
EPD
$84.3B
– –
-13,461
Closed -$351K
ET icon
64
Energy Transfer Partners
ET
$73.4B
– –
-14,000
Closed -$243K
EVOK
65
DELISTED
Evoke Pharma
EVOK
– –
-72
Closed -$35K
GE icon
66
GE Aerospace
GE
$355B
– –
-4,596
Closed -$533K
IMDX
67
Insight Molecular Diagnostics
IMDX
$135M
– –
-1,028
Closed -$155K
RDHL
68
Redhill Biopharma
RDHL
$4.02M
– –
-38
Closed -$408K
SLB icon
69
SLB Ltd
SLB
$85.1B
– –
-58,100
Closed -$4.05M
GBT
70
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-11,300
Closed -$351K
HSTO
71
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-70
Closed -$77K
CSLT
72
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
– –
-10,000
Closed -$43K
PETX
73
DELISTED
Aratana Therapeutics, Inc.
PETX
– –
-12,000
Closed -$74K
1 2
3

Similar funds

ACM
Arini Captial Management London, United Kingdom $975M AUM
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
ZI
ZEGA Investments Palm Beach Gardens, Florida $973M AUM 27.27% 1-Year Est. Return
RIA
RPG Investment Advisory Pleasanton, California $973M AUM 39.93% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PC
Permanens Capital New York $972M AUM 27.73% 1-Year Est. Return

Family Management's Q4 2017 Portfolio in Review

As of Q4 2017, Family Management held 73 positions worth $143M, down 1.9% from $146M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Family Management withdrew a net $11.6M in Q4 2017, closing 14 positions and reducing 36 holdings. Its most notable exit was SLB Ltd, an estimated $4.05M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Family Management opened a new position in Lennar Class A worth $2.51M.

  • Family Management's largest Q4 2017 buy was Lennar Class A: 40,964 shares worth $2.51M.
  • Family Management added most to Rithm Property Trust in Q4 2017, an estimated $1.12M increase.
  • Family Management's biggest Q4 2017 reduction was Intel, cutting an estimated $4.07M.
  • Family Management fully exited SLB Ltd in Q4 2017, selling an estimated $4.05M.
  • Family Management's ten largest holdings make up 45% of its $143M portfolio in Q4 2017.
  • Family Management opened 6 new positions and closed 14 in Q4 2017.
  • Family Management's portfolio value fell 1.9% quarter-over-quarter to $143M.

Based on Family Management's 13F filing for Q4 2017, filed 15 Feb 2018.